The Goldman Sachs Group Downgrades Option Care Health (NASDAQ:OPCH) to Neutral

The Goldman Sachs Group cut shares of Option Care Health (NASDAQ:OPCH) from a buy rating to a neutral rating in a research report released on Monday morning, MarketBeat Ratings reports. The Goldman Sachs Group currently has $27.00 price target on the stock.

Several other research firms have also recently commented on OPCH. Barrington Research reduced their target price on Option Care Health from $40.00 to $32.00 and set an “outperform” rating for the company in a research note on Thursday, October 31st. JMP Securities increased their price target on shares of Option Care Health from $36.00 to $37.00 and gave the stock a “market outperform” rating in a research report on Monday, September 30th. Truist Financial lowered their price objective on Option Care Health from $41.00 to $34.00 and set a “buy” rating for the company in a report on Friday. Bank of America downgraded Option Care Health from a “buy” rating to a “neutral” rating and reduced their target price for the stock from $43.00 to $29.00 in a report on Wednesday, October 30th. Finally, Jefferies Financial Group downgraded Option Care Health from a “buy” rating to a “hold” rating and lowered their price target for the company from $38.00 to $26.00 in a report on Thursday, October 31st. Three investment analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $30.83.

Option Care Health Stock Performance

NASDAQ:OPCH opened at $22.49 on Monday. The stock has a market cap of $3.83 billion, a P/E ratio of 18.90, a PEG ratio of 1.90 and a beta of 1.32. Option Care Health has a 1-year low of $22.46 and a 1-year high of $34.63. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.73 and a quick ratio of 1.32. The firm has a 50-day moving average of $30.31 and a two-hundred day moving average of $29.85.

Insider Activity

In related news, Director Elizabeth Quadros Betten sold 47,531 shares of the business’s stock in a transaction that occurred on Wednesday, August 21st. The stock was sold at an average price of $31.09, for a total transaction of $1,477,738.79. Following the completion of the transaction, the director now owns 21,339 shares in the company, valued at $663,429.51. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. In related news, CFO Michael H. Shapiro sold 23,217 shares of the stock in a transaction dated Thursday, August 22nd. The shares were sold at an average price of $30.95, for a total value of $718,566.15. Following the sale, the chief financial officer now owns 247,317 shares of the company’s stock, valued at $7,654,461.15. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Elizabeth Quadros Betten sold 47,531 shares of Option Care Health stock in a transaction dated Wednesday, August 21st. The shares were sold at an average price of $31.09, for a total transaction of $1,477,738.79. Following the completion of the sale, the director now owns 21,339 shares in the company, valued at approximately $663,429.51. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 0.64% of the company’s stock.

Institutional Investors Weigh In On Option Care Health

A number of hedge funds have recently made changes to their positions in OPCH. Thrivent Financial for Lutherans grew its holdings in Option Care Health by 9.1% in the 2nd quarter. Thrivent Financial for Lutherans now owns 5,459,119 shares of the company’s stock worth $151,218,000 after buying an additional 455,310 shares in the last quarter. Westfield Capital Management Co. LP increased its holdings in shares of Option Care Health by 15.4% during the first quarter. Westfield Capital Management Co. LP now owns 5,171,385 shares of the company’s stock valued at $173,448,000 after purchasing an additional 688,653 shares during the period. Dimensional Fund Advisors LP increased its holdings in shares of Option Care Health by 6.5% during the second quarter. Dimensional Fund Advisors LP now owns 3,605,271 shares of the company’s stock valued at $99,870,000 after purchasing an additional 218,844 shares during the period. Magnetar Financial LLC raised its stake in shares of Option Care Health by 124.8% during the second quarter. Magnetar Financial LLC now owns 2,481,935 shares of the company’s stock valued at $68,750,000 after purchasing an additional 1,377,929 shares in the last quarter. Finally, Massachusetts Financial Services Co. MA bought a new position in Option Care Health in the 2nd quarter valued at about $68,003,000. Institutional investors own 98.05% of the company’s stock.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.